| Stage | AAMI | % of rev | BX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $185M | 100.00% | $5.0B | 100.00% | BX ×27.25 |
| Gross profit | $64M | 34.52% | $5.0B | 100.00% | BX +65.5pp |
| Operating income | $32M | 17.50% | $2.7B | 52.90% | BX +35.4pp |
| Pre-tax income | $39M | 20.96% | $2.8B | 55.68% | BX +34.7pp |
| Net income | $29M | 15.88% | $2.4B | 46.71% | BX +30.8pp |
| Stage | AAMI | BX | Gap · A − B |
|---|---|---|---|
| Revenue | $185M100.00% | $5.0B100.00% | BX ×27.25 |
| Gross profit | 34.52%$64M | 100.00%$5.0B | BX +65.5pp |
| Operating income | 17.50%$32M | 52.90%$2.7B | BX +35.4pp |
| Pre-tax income | 20.96%$39M | 55.68%$2.8B | BX +34.7pp |
| Net income |
| 15.88%$29M |
| 46.71%$2.4B |
| BX +30.8pp |
No shared counterparties.